Author name: DrugPatentWatch

Introduction: The High-Stakes Chess Match of Paragraph IV Litigation In the world of pharmaceuticals, few events are as consequential as […]

Executive Summary In the pharmaceutical industry, where the cost of bringing a single new drug to market can exceed $2.2

Executive Summary: The Dissolution of the Détente The pharmaceutical ecosystem currently faces a structural realignment of unprecedented magnitude. For decades,

Beyond the Legal Formality: Why Patent Strategy is a Core Business Imperative For too long, patent strategy has been relegated

The traditional American pharmaceutical supply chain operates as a fortress of opacity, defended by a complex triad of pharmacy benefit

The enactment of the Inflation Reduction Act (IRA) of 2022 represents a paradigmatic shift in the United States biopharmaceutical landscape,

The global pharmaceutical industry reached a valuation of $1.6 trillion in 2023.1 Projections show this market will hit $2.35 trillion

The global pharmaceutical landscape is currently navigating a period of unprecedented fiscal exposure, characterized by a looming “super-cliff” of patent

The pharmaceutical industry has moved away from the traditional model of innovation where a single patent protects a drug for